
  
    
      
        Background_NNP
        After_IN lung_NN ,_, prostate_NN ,_, and_CC breast_NN cancer_NN ,_, colorectal_NN
        cancer_NN ranks_NNS as_IN a_DT leading_VBG source_NN of_IN cancer_NN mortality_NN ._. [_NN 1_CD ]_NN
        Nationally_NNP ,_, although_IN death_NN rates_NNS have_VBP been_VBN declining_VBG since_IN
        the_DT mid-_NN 1980_CD s_VBZ ,_, this_DT trend_NN is_VBZ not_RB consistent_JJ across_IN all_DT
        ethnic_JJ groups_NNS ._. [_NN 2_CD ]_NN Specifically_RB ,_, in_IN the_DT past_JJ 10_CD years_NNS the_DT
        death_NN rate_NN for_IN Caucasians_NNP has_VBZ been_VBN decreasing_VBG at_IN nearly_RB
        twice_RB the_DT rate_NN as_IN that_DT for_IN African_NNP Americans_NNPS ,_, and_CC for_IN
        Native_NNP Americans_NNPS the_DT rate_NN has_VBZ actually_RB been_VBN increasing_VBG ._. [_NN 3_CD
        4_CD ]_NN Among_IN Asian_JJ ethnic_JJ groups_NNS ,_, Chinese_NNP and_CC Filipinos_NNPS suffer_VBP
        a_DT higher_JJR death_NN rate_NN than_IN do_VBP the_DT Japanese_NN ._. [_NN 5_CD ]_NN These_DT
        ethnic_JJ disparities_NNS appear_VBP largely_RB driven_VBN by_IN differential_NN
        stage_NN distribution_NN (_( e_SYM ._. g_SYM ._. ,_, more_JJR advanced_VBD stage_NN cases_NNS at_IN
        presentation_NN )_) ._. Underutilization_NNP of_IN cancer_NN screening_NN appears_VBZ
        a_DT key_JJ factor_NN ._. [_NN 6_CD ]_NN However_RB ,_, studies_NNS have_VBP found_VBN that_IN even_RB
        after_IN controlling_VBG for_IN stage_NN at_IN diagnosis_NN ,_, significant_JJ
        ethnic_JJ differences_NNS remain_VBP ._. [_NN 7_CD ]_NN
        How_WRB can_MD one_CD explain_VB cancer_NN survival_NN differences_NNS that_WDT
        persist_VBP after_IN adjustment_NN for_IN stage_NN ?_. Biological_JJ theories_NNS
        suggest_VBP that_IN members_NNS of_IN certain_JJ ethnic_JJ groups_NNS are_VBP
        genetically_RB predisposed_JJ to_TO more_RBR aggressive_JJ forms_NNS of_IN the_DT
        disease_NN ,_, differ_VB in_IN host-tumor_JJ interactions_NNS ,_, or_CC are_VBP more_RBR
        likely_JJ to_TO have_VB contributing_VBG comorbid_NN conditions_NNS ._. Wudel_NNP et_CC
        al_NN ._. (_( 2002_CD )_) recently_RB reported_VBD that_DT colorectal_NN cancer_NN
        survival_NN differences_NNS between_IN Caucasians_NNP and_CC African_NNP
        Americans_NNPS could_MD not_RB be_VB explained_VBN by_IN measurable_JJ differences_NNS
        in_IN treatment_NN ._. [_NN 8_CD ]_NN Neuhausen_NNP has_VBZ proposed_VBN a_DT
        multi-factorial_JJ biology-utilization_JJ model_NN ._. [_NN 9_CD ]_NN
        Environmental_NNP theories_NNS propose_VBP that_IN behavioral_JJ or_CC
        socioeconomic_JJ factors_NNS leading_VBG to_TO differential_NN utilization_NN
        of_IN medical_JJ care_NN are_VBP responsible_JJ ._. Varying_JJ utilization_NN of_IN ,_, as_RB
        well_RB as_IN access_NN to_TO health_NN care_NN has_VBZ been_VBN reported_VBN as_IN an_DT
        explanation_NN ._. [_NN 10_CD 11_CD 12_CD ]_NN Schrijvers_NNP et_CC al_NN ._. (_( 1997_CD )_) have_VBP
        described_VBN a_DT relation_NN between_IN socioeconomic_JJ status_NN and_CC
        comorbidity_NN ._. [_NN 13_CD ]_NN Evidence_NN of_IN interaction_NN between_IN age_NN and_CC
        socioeconomic_JJ status_NN has_VBZ also_RB been_VBN reported_VBN ._. [_NN 14_CD ]_NN
        Hawaii_NNP 's_POS diverse_JJ ethnic_JJ composition_NN combined_VBN with_IN its_PRP$
        long-standing_JJ statewide_JJ cancer_NN registry_NN ,_, the_DT Hawaii_NNP Tumor_NNP
        Registry_NNP (_( HTR_NNP )_) ,_, offer_NN an_DT ideal_JJ setting_NN for_IN examining_VBG ethnic_JJ
        differences_NNS in_IN cancer_NN survival_NN ._. Previous_JJ research_NN has_VBZ
        documented_VBN significant_JJ survival_NN disparities_NNS among_IN the_DT major_JJ
        ethnic_JJ groups_NNS (_( Caucasian_NNP ,_, Japanese_JJ ,_, Hawaiian_JJ ,_, Filipino_NNP ,_, and_CC
        Chinese_JJ )_) in_IN the_DT state_NN ._. In_IN 1978_CD ,_, Nomura_NNP et_CC al_NN ._. found_VBD that_IN
        Japanese_JJ patients_NNS had_VBD a_DT nearly_RB one-third_NN higher_JJR survival_NN
        rate_NN than_IN Caucasians_NNP ._. [_NN 15_CD ]_NN Hirohata_NNP et_CC al_NN ._. (_( 1977_CD )_)
        described_VBD better_JJR survival_NN rates_NNS among_IN Japanese_JJ and_CC
        Caucasians_NNP than_IN among_IN Filipinos_NNPS and_CC Hawaiians_NNP ,_, even_RB after_IN
        adjusting_VBG for_IN age_NN ,_, gender_NN ,_, and_CC extent_NN of_IN disease_NN at_IN
        diagnosis_NN ._. [_NN 16_CD ]_NN Wegner_NNP et_CC al_NN ._. (_( 1982_CD )_) analyzed_VBD HTR_NNP data_NNS
        from_IN 1960_CD -_: 1974_CD and_CC found_VBD the_DT same_JJ pattern_NN of_IN differences_NNS ,_,
        which_WDT also_RB could_MD not_RB be_VB explained_VBN by_IN any_DT of_IN the_DT available_JJ
        covariates_NNS ._. [_NN 17_CD ]_NN
        The_DT goal_NN of_IN the_DT present_JJ study_NN is_VBZ to_TO examine_VB trends_NNS in_IN
        recent_JJ survival_NN rates_NNS ._. The_DT HTR_NNP data_NN that_WDT was_VBD incorporated_VBN
        in_IN the_DT Wegner_NNP (_( 1982_CD )_) study_NN is_VBZ still_RB available_JJ as_IN is_VBZ more_RBR
        recent_JJ data_NNS up_IN to_TO the_DT year_NN 2000_CD ,_, allowing_VBG for_IN an_DT
        examination_NN of_IN survival_NN patterns_NNS over_IN time_NN ._. Improved_JJ
        survival_NN rates_NNS for_IN cancer_NN patients_NNS were_VBD observed_VBN by_IN Hinds_NNP
        et_CC al_NN ._. (_( 1983_CD )_) during_IN the_DT years_NNS 1960_CD -_: 1974_CD ._. [_NN 18_CD ]_NN More_RBR
        recently_RB ,_, Maskarinec_NNP et_CC al_NN ._. (_( 1999_CD )_) have_VBP described_VBN improved_VBN
        breast_NN cancer_NN survival_NN among_IN all_DT ethnic_JJ groups_NNS for_IN
        1970_CD -_: 1990_CD ._. [_NN 19_CD ]_NN Also_RB ,_, for_IN the_DT years_NNS 1995_CD -_: 1998_CD it_PRP was_VBD
        found_VBN that_IN all_DT ethnic_JJ disparities_NNS in_IN breast_NN cancer_NN survival_NN
        were_VBD eliminated_VBN once_RB TNM_NNP Stage_NN had_VBD been_VBN controlled_VBN ._. [_NN 20_CD ]_NN
        These_DT findings_NNS largely_RB fail_VBP to_TO support_VB purely_RB biologic_JJ
        explanations_NNS of_IN disparate_JJ colorectal_NN cancer_NN survival_NN ._.
        Differential_NNP utilization_NN of_IN health_NN care_NN or_CC access_NN to_TO health_NN
        care_NN appears_VBZ more_RBR important_JJ ._.
        In_IN Hawaii_NNP ,_, the_DT passage_NN of_IN time_NN has_VBZ brought_VBN general_JJ
        improvements_NNS in_IN medical_JJ care_NN and_CC also_RB narrowed_VBD disparities_NNS
        in_IN access_NN to_TO medical_JJ care_NN ._. Utilization_NN of_IN screening_NN
        procedures_NNS continues_VBZ to_TO vary_VB among_IN ethnic_JJ groups_NNS ,_, however_RB ._.
        At_IN the_DT onset_NN of_IN this_DT study_NN ,_, we_PRP hypothesized_VBN that_IN ,_, over_IN the_DT
        past_JJ 30_CD years_NNS ,_, improved_VBN cancer_NN screening_NN and_CC treatment_NN ,_, as_RB
        well_RB as_IN better_JJR access_NN to_TO medical_JJ care_NN across_IN all_DT ethnic_JJ
        groups_NNS has_VBZ both_DT improved_VBN survival_NN rates_NNS and_CC reduced_VBN ethnic_JJ
        differences_NNS in_IN colorectal_NN cancer_NN survival_NN ._. We_PRP further_RBR
        predicted_VBD that_DT stage_NN at_IN diagnosis_NN ,_, age_NN ,_, and_CC gender_NN could_MD
        explain_VB most_JJS remaining_VBG survival_NN differences_NNS ,_, although_IN we_PRP
        questioned_VBD the_DT role_NN of_IN other_JJ factors_NNS such_JJ as_IN treatment_NN
        utilization_NN and_CC co-morbid_JJ disease_NN ._.
      
      
        Methods_NNP
        
          Population_NNP and_CC Sample_NNP
          The_DT population_NN of_IN Hawaii_NNP resides_VBZ on_IN seven_CD islands_NNS with_IN
          80_CD %_NN on_IN the_DT island_NN of_IN Oahu_NNP and_CC is_VBZ estimated_VBN at_IN 1_CD ._. 2_CD million_CD
          with_IN approximately_RB 580_CD ,_, 000_CD women_NNS ._. [_NN 21_CD ]_NN Close_NNP to_TO 13_CD %_NN of_IN
          residents_NNS are_VBP 65_CD years_NNS and_CC older_JJR and_CC 40_CD %_NN are_VBP 40_CD years_NNS and_CC
          older_JJR ._. The_DT majority_NN of_IN the_DT population_NN is_VBZ of_IN Asian_JJ and_CC
          Pacific_NNP Islander_NNP descent_NN :_: 24_CD ._. 1_LS %_NN of_IN the_DT population_NN in_IN 1990_CD
          were_VBD Caucasian_NNP ,_, 20_CD ._. 4_LS %_NN Japanese_JJ ,_, 18_CD ._. 8_CD %_NN Native_NNP Hawaiian_JJ ,_,
          11_CD ._. 4_LS %_NN Filipino_NNP ,_, 4_CD ._. 7_CD %_NN Chinese_JJ ,_, and_CC the_DT rest_NN other_JJ ethnic_JJ
          groups_NNS ._. However_RB ,_, over_IN the_DT period_NN of_IN this_DT study_NN ,_,
          differences_NNS in_IN age_NN distribution_NN within_IN various_JJ ethnic_JJ
          groups_NNS in_IN Hawaii_NNP have_VBP driven_VBN some_DT differences_NNS in_IN the_DT
          actual_JJ proportions_NNS of_IN individuals_NNS with_IN cancer_NN ._.
          All_DT data_NNS were_VBD ascertained_JJ through_IN the_DT Hawaii_NNP Tumor_NNP
          Registry_NNP (_( HTR_NNP )_) ,_, which_WDT provides_VBZ population-based_JJ coverage_NN
          of_IN all_DT newly_RB diagnosed_VBN cancer_NN cases_NNS and_CC subsequent_JJ
          follow-up_JJ status_NN for_IN residents_NNS of_IN Hawaii_NNP ._. The_DT HTR_NNP was_VBD
          established_VBN in_IN 1960_CD and_CC it_PRP became_VBD part_NN of_IN the_DT
          Surveillance_NNP ,_, Epidemiology_NNP ,_, and_CC End_NN Results_NNS (_( SEER_NNP )_)
          program_NN in_IN 1973_CD ._. Quality_JJ control_NN reviews_NNS have_VBP shown_VBN that_IN
          case-ascertainment_JJ through_IN HTR_NNP is_VBZ virtually_RB complete_JJ ._.
          Over_IN 99_CD %_NN of_IN cancer_NN cases_NNS reported_VBD to_TO the_DT registry_NN are_VBP
          histologically_RB confirmed_VBN [_NN 22_CD ]_NN and_CC less_JJR than_IN 2_CD %_NN of_IN cases_NNS
          are_VBP identified_VBN through_IN death_NN certificates_NNS only_RB ._. Whenever_WRB
          possible_JJ ,_, the_DT HTR_NNP follows_VBZ cases_NNS until_IN death_NN through_IN
          regular_JJ linkages_NNS with_IN the_DT Hawaii_NNP Department_NNP of_IN Health_NNP 's_POS
          death_NN records_NNS ,_, hospital-based_JJ registries_NNS ,_, and_CC additional_JJ
          sources_NNS of_IN mortality_NN information_NN ._. In_IN accordance_NN with_IN SEER_NNP
          rules_NNS ,_, less_JJR than_IN 5_CD %_NN of_IN cases_NNS are_VBP lost_VBN to_TO follow-up_JJ ._. The_DT
          ethnicity_NN classification_NN in_IN the_DT HTR_NNP is_VBZ based_VBN on_IN
          self-reports_JJ by_IN patients_NNS ._. Information_NNP on_IN the_DT first_JJ course_NN
          of_IN treatment_NN (_( surgery_NN ,_, chemotherapy_NN ,_, radiation_NN ,_, and_CC
          hormone_NN therapy_NN )_) is_VBZ also_RB collected_VBN ._. [_NN 23_CD ]_NN
          From_IN the_DT HTR_NNP ,_, all_DT patients_NNS diagnosed_VBN with_IN colorectal_NN
          cancer_NN (_( ICD-O-_NNP 2_CD codes_NNS :_: C_NNP 18_CD ._. 0_CD -_: C_NNP 18_CD ._. 9_CD ,_, C_NNP 19_CD ._. 9_CD ,_, C_NNP 20_CD ._. 9_CD ,_,
          C_NNP 21_CD ._. 0_CD -_: C_NNP 21_CD ._. 2_LS ,_, C_NNP 21_CD ._. 8_CD )_) from_IN 1960_CD -_: 2000_CD were_VBD extracted_VBN ._. Of_IN the_DT
          17_CD ,_, 416_CD pathologically_RB confirmed_VBD cases_NNS of_IN invasive_JJ
          colorectal_NN cancer_NN ,_, we_PRP excluded_VBD 757_CD patients_NNS who_WP were_VBD not_RB
          from_IN the_DT five_CD major_JJ ethnic_JJ groups_NNS (_( Caucasian_NNP ,_, Japanese_JJ ,_,
          Hawaiian_JJ ,_, Filipino_NNP ,_, and_CC Chinese_JJ )_) and_CC 235_CD patients_NNS for_IN
          whom_WP the_DT diagnosis_NN date_NN was_VBD unknown_JJ ,_, leaving_VBG a_DT total_JJ
          sample_NN of_IN 16_CD ,_, 424_CD cases_NNS for_IN analysis_NN ._.
        
        
          Statistical_NNP Analyses_NNS
          Data_NNP were_VBD first_RB examined_VBD for_IN ethnic_JJ differences_NNS by_IN
          cohort_NN across_IN stage_NN at_IN diagnosis_NN ,_, age_NN ,_, sex_NN ,_, and_CC cause_NN of_IN
          death_NN using_VBG the_DT likelihood_NN ratio_NN χ_NN 2_CD statistic_NN ._. This_DT
          statistic_NN is_VBZ interpreted_VBN in_IN the_DT same_JJ manner_NN as_IN the_DT
          Pearson_NNP χ_NN 2_CD ,_, but_CC provides_VBZ greater_JJR precision_NN ._. Next_JJ ,_, the_DT
          SAS_NNP procedure_NN PHREG_NNP ,_, [_NN 24_CD ]_NN which_WDT performs_VBZ regression_NN
          analyses_NNS based_VBN on_IN the_DT Cox_NNP proportional_JJ hazards_NNS model_NN ,_, was_VBD
          used_VBN to_TO conduct_VB survival_NN analyses_NNS ._. As_IN a_DT test_NN of_IN the_DT
          validity_NN of_IN the_DT proportional_JJ hazards_NNS assumption_NN (_( that_IN the_DT
          hazard_NN ratio_NN does_VBZ not_RB change_VB over_IN time_NN )_) ,_, the_DT Cox_NNP
          proportional_JJ hazards_NNS regression_NN was_VBD performed_VBN with_IN a_DT
          variable_JJ calculated_VBN as_IN the_DT mean_NN deviated_VBD natural_JJ log_NN of_IN
          time_NN ._. Significance_NN of_IN this_DT variable_JJ would_MD imply_VB a_DT
          violation_NN of_IN the_DT proportional_JJ hazards_NNS assumption_NN ._.
          Survival_NNP (_( survivor_NN function_NN )_) estimates_NNS (_( used_VBN for_IN figures_NNS )_)
          were_VBD based_VBN on_IN the_DT fitted_JJ proportional_JJ hazards_NNS model_NN ,_, and_CC
          can_MD be_VB interpreted_VBN as_IN the_DT estimates_NNS for_IN the_DT survivor_NN
          functions_NNS controlling_VBG for_IN the_DT effects_NNS of_IN the_DT covariates_NNS ._.
          [_NN 25_CD ]_NN The_DT same_JJ analyses_NNS were_VBD conducted_VBN in_IN each_DT of_IN three_CD
          separate_JJ cohorts_NNS determined_VBN by_IN the_DT year_NN of_IN diagnosis_NN :_:
          1960_CD -_: 1974_CD ,_, 1975_CD -_: 1987_CD ,_, and_CC 1988_CD -_: 2000_CD ._. The_DT years_NNS for_IN the_DT
          first_JJ cohort_NN were_VBD chosen_VBN to_TO be_VB consistent_JJ with_IN the_DT study_NN
          conducted_VBN by_IN Wegner_NNP et_CC al_NN ._. [_NN 17_CD ]_NN
          The_DT starting_VBG year_NN for_IN the_DT third_JJ cohort_NN was_VBD chosen_VBN as_IN
          1988_CD because_IN that_DT was_VBD the_DT first_JJ year_NN in_IN which_WDT TNM_NNP staging_NN
          data_NNS (_( tumor_NN size_NN ,_, node_NN status_NN ,_, and_CC metastases_NNS )_) became_VBD
          available_JJ in_IN the_DT HTR_NNP ._. [_NN 26_CD ]_NN With_IN TNM_NNP stage_NN data_NNS ,_, a_DT
          comparison_NN between_IN the_DT predictive_JJ value_NN of_IN this_DT more_RBR
          comprehensive_JJ form_NN of_IN staging_NN (_( 0_CD ,_, I_PRP ,_, IIA_NNP ,_, IIB_NNP ,_, IIIA_NNP ,_,
          IIIB_NNP ,_, and_CC IV_NNP )_) and_CC the_DT SEER_NNP staging_NN (_( local_JJ ,_, regional_JJ ,_,
          distant_JJ )_) could_MD be_VB made_VBN ._. [_NN 26_CD ]_NN The_DT was_VBD accomplished_VBN by_IN
          computing_VBG the_DT increment_NN in_IN model_NN fit_NN after_IN the_DT TNM_NNP stage_NN
          variable_NN had_VBD been_VBN added_VBN to_TO model_VB containing_VBG the_DT SEER_NNP
          stage_NN variable_JJ ._. The_DT likelihood_NN ratio_NN statistic_NN provides_VBZ
          this_DT information_NN and_CC is_VBZ distributed_VBN as_IN chi-square_JJ ,_,
          allowing_VBG for_IN determination_NN of_IN statistical_JJ significance_NN ._.
          The_DT years_NNS for_IN the_DT second_JJ cohort_NN consisted_VBD simply_RB of_IN the_DT
          years_NNS between_IN cohorts_NNS one_CD and_CC three_CD ._.
          Within_IN each_DT cohort_NN two_CD sets_NNS of_IN survival_NN analyses_NNS were_VBD
          performed_VBN :_: In_IN the_DT first_JJ ,_, an_DT event_NN was_VBD considered_VBN to_TO have_VB
          occurred_VBN if_IN a_DT patient_NN died_VBD as_IN a_DT result_NN of_IN colorectal_NN
          cancer_NN ;_: in_IN the_DT second_NN ,_, death_NN by_IN any_DT other_JJ cause_NN was_VBD
          considered_VBN an_DT event_NN ._. This_DT allowed_VBN for_IN an_DT assessment_NN of_IN
          whether_IN or_CC not_RB changing_VBG colorectal_NN cancer_NN survival_NN trends_NNS
          were_VBD consistent_JJ with_IN general_JJ survival_NN trends_NNS ._. Censored_NNP
          values_NNS included_VBD patients_NNS alive_JJ at_IN the_DT last_JJ data_NN
          collection_NN and_CC patients_NNS lost_VBD to_TO follow-up_JJ ._. In_IN all_DT
          analyses_NNS the_DT effect_NN of_IN ethnicity_NN on_IN survival_NN ,_, while_IN
          controlling_VBG for_IN the_DT variables_NNS stage_VBP at_IN diagnosis_NN (_( local_JJ ,_,
          regional_JJ ,_, distant_JJ )_) ,_, age_NN ,_, sex_NN ,_, and_CC year_NN of_IN diagnosis_NN (_( to_TO
          control_VB for_IN any_DT linear_JJ time_NN trends_NNS existing_VBG within_IN
          cohorts_NNS )_) ,_, was_VBD assessed_VBN using_VBG a_DT hierarchical_JJ approach_NN in_IN
          which_WDT a_DT model_NN including_VBG ethnicity_NN was_VBD compared_VBN to_TO one_CD
          that_WDT did_VBD not_RB ._. Age_NNP and_CC year_NN of_IN diagnosis_NN were_VBD treated_VBN as_IN
          continuous_JJ variables_NNS ,_, as_IN examinations_NNS did_VBD not_RB reveal_VB any_DT
          nonlinear_NN associations_NNS ._.
        
      
      
        Results_NNS
        Tables_NNP 1_CD and_CC 2_CD provide_VB frequency_NN and_CC percentage_NN
        distribution_NN data_NNS for_IN stage_NN at_IN diagnosis_NN ,_, age_NN ,_, sex_NN ,_, and_CC
        cause_NN of_IN death_NN by_IN ethnicity_NN and_CC cohort_NN ._. The_DT average_JJ ages_NNS
        for_IN each_DT stage_NN at_IN diagnosis_NN were_VBD 66_CD ._. 6_CD years_NNS for_IN local_JJ ,_, 65_CD ._. 9_CD
        years_NNS for_IN regional_JJ ,_, and_CC 65_CD ._. 5_LS years_NNS for_IN distant_JJ ._. For_IN each_DT
        variable_JJ ,_, significant_JJ ethnic_JJ differences_NNS were_VBD observed_VBN ._.
        When_WRB compared_VBN to_TO the_DT other_JJ ethnic_JJ groups_NNS ,_, Hawaiians_NNP in_IN all_DT
        three_CD cohorts_NNS were_VBD diagnosed_VBN at_IN a_DT more_JJR advanced_VBD stage_NN
        [_NN Likelihood_NNP Ratio_NNP χ_NN 2_CD (_( 8_CD )_) =_SYM 36_CD ._. 8_CD ,_, 25_CD ._. 0_CD ,_, and_CC 46_CD ._. 0_CD ;_: 
        p_NN <_NN ._. 0001_CD ,_, 
        p_NN <_NN ._. 01_CD ,_, and_CC 
        p_NN <_NN ._. 0001_CD respectively_RB ]_NN and_CC were_VBD
        more_RBR likely_JJ to_TO have_VB died_VBN from_IN colorectal_NN cancer_NN (_( as_IN opposed_VBN
        to_TO death_NN by_IN other_JJ causes_NNS or_CC still_RB alive_JJ )_) [_NN Likelihood_NNP Ratio_NNP
        χ_NN 2_CD (_( 8_CD )_) =_SYM 36_CD ._. 5_LS ,_, 71_CD ._. 2_LS ,_, and_CC 69_CD ._. 6_CD ;_: p_NN <_NN ._. 0001_CD for_IN all_DT ]_NN ._.
        Hawaiians_NNP also_RB were_VBD significantly_RB younger_JJR within_IN cohorts_NNS 2_CD
        and_CC 3_CD [_NN Likelihood_NNP Ratio_NNP χ_NN 2_CD (_( 4_LS )_) =_SYM 92_CD ._. 3_LS and_CC 180_CD ._. 5_LS ;_: 
        p_NN <_NN ._. 0001_CD for_IN both_DT ]_NN ._. When_WRB compared_VBN
        to_TO the_DT other_JJ ethnic_JJ groups_NNS ,_, Filipinos_NNPS had_VBD a_DT significantly_RB
        higher_JJR proportion_NN of_IN males_NNS in_IN all_DT three_CD cohorts_NNS [_NN Likelihood_NNP
        Ratio_NNP χ_NN 2_CD (_( 4_LS )_) =_SYM 140_CD ._. 1_LS ,_, 92_CD ._. 7_CD ,_, and_CC 32_CD ._. 1_LS ;_: 
        p_NN <_NN ._. 0001_CD for_IN all_DT ]_NN ._.
        Figure_NN 1_CD presents_VBZ the_DT survivor_NN function_NN plots_NNS (_( stratified_JJ
        by_IN ethnicity_NN )_) for_IN each_DT cohort_NN and_CC for_IN each_DT cause_NN of_IN death_NN
        category_NN (_( controlled_VBN for_IN stage_NN at_IN diagnosis_NN ,_, year_NN of_IN
        diagnosis_NN ,_, age_NN ,_, and_CC sex_NN )_) ._. The_DT corresponding_JJ five-year_JJ
        survivor_NN estimates_NNS with_IN 95_CD %_NN confidence_NN intervals_NNS are_VBP shown_VBN
        in_IN Table_NNP 3_CD ,_, and_CC the_DT parameter_NN estimates_NNS for_IN each_DT Cox_NNP
        regression_NN model_NN are_VBP provided_VBN in_IN Table_NNP 4_CD ._. Unadjusted_NNP
        five-year_JJ survival_NN rates_NNS for_IN each_DT ethnic_JJ group_NN were_VBD 80_CD ._. 5_LS %_NN
        for_IN Japanese_JJ ,_, 79_CD ._. 4_LS %_NN for_IN Caucasian_NNP ,_, 78_CD ._. 8_CD %_NN for_IN Chinese_JJ ,_, 76_CD ._. 4_LS %_NN
        for_IN Filipino_NNP ,_, and_CC 72_CD ._. 5_LS %_NN for_IN Hawaiian_JJ ._. The_DT test_NN of_IN the_DT
        validity_NN of_IN the_DT proportional_JJ hazards_NNS assumption_NN with_IN the_DT
        variable_JJ [_NN 
        log_NN 
        
          e_SYM 
         (_( 
        time_NN )_) -_: 0_CD ._. 52_CD ]_NN indicated_VBD no_DT violation_NN
        [_NN χ_NN 2_CD (_( 1_LS )_) =_SYM 0_CD ._. 13_CD ,_, 
        p_NN =_SYM 0_CD ._. 72_CD ]_NN ._.
        When_WRB an_DT event_NN was_VBD considered_VBN death_NN by_IN colorectal_NN cancer_NN ,_,
        significant_JJ ethnic_JJ differences_NNS were_VBD found_VBN for_IN all_DT three_CD
        cohorts_NNS [_NN Likelihood_NNP Ratio_NNP χ_NN 2_CD (_( 4_LS )_) =_SYM 20_CD ._. 0_CD ,_, 23_CD ._. 1_LS ,_, and_CC 12_CD ._. 0_CD ;_: 
        p_NN <_NN ._. 001_CD ,_, 
        p_NN <_NN ._. 001_CD ,_, and_CC 
        p_NN <_NN ._. 05_CD respectively_RB ]_NN ._. An_DT
        examination_NN of_IN the_DT confidence_NN intervals_NNS for_IN cohort_NN 1_CD
        indicated_VBD that_IN Japanese_JJ and_CC Caucasian_NNP patients_NNS had_VBD
        significantly_RB longer_RBR five-year_JJ survival_NN than_IN Filipino_NNP and_CC
        Hawaiian_JJ patients_NNS ._. For_IN the_DT second_JJ cohort_NN ,_, the_DT confidence_NN
        intervals_NNS indicated_VBD that_IN Caucasians_NNP had_VBD a_DT significantly_RB
        longer_JJR survival_NN time_NN than_IN Filipinos_NNPS ;_: and_CC in_IN the_DT third_JJ
        cohort_NN ,_, Hawaiians_NNP had_VBD significantly_RB shorter_JJR survival_NN time_NN
        than_IN all_DT other_JJ ethnic_JJ groups_NNS ._. When_WRB an_DT event_NN was_VBD considered_VBN
        any_DT death_NN not_RB caused_VBN by_IN colorectal_NN cancer_NN ,_, significant_JJ
        ethnic_JJ differences_NNS were_VBD again_RB found_VBN for_IN all_DT three_CD cohorts_NNS
        [_NN Likelihood_NNP Ratio_NNP χ_NN 2_CD (_( 4_LS )_) =_SYM 46_CD ._. 3_LS ,_, 73_CD ._. 3_LS ,_, and_CC 57_CD ._. 9_CD ;_: 
        p_NN <_NN ._. 0001_CD for_IN all_DT ]_NN ._. Confidence_NN
        intervals_NNS indicated_VBD that_IN the_DT Japanese_NN always_RB had_VBD a_DT
        significantly_RB higher_JJR survival_NN rate_NN than_IN at_IN least_JJS one_CD other_JJ
        ethnic_JJ group_NN ._.
        Results_NNS were_VBD largely_RB consistent_JJ with_IN our_PRP$ hypothesis_NNS ,_, but_CC
        with_IN one_CD major_JJ exception_NN :_: the_DT persistently_RB low_JJ Hawaiian_JJ
        colorectal_NN cancer_NN survival_NN in_IN cohort_NN 3_CD ._. This_DT unpredicted_JJ
        finding_NN led_VBN to_TO post_VB hoc_FW analyses_NNS that_WDT were_VBD identical_JJ to_TO the_DT
        previous_JJ Cox_NNP regression_NN models_NNS ,_, but_CC included_VBD the_DT available_JJ
        treatment_NN variables_NNS (_( surgery_NN ,_, chemotherapy_NN ,_, radiation_NN ,_, and_CC
        hormone_NN therapy_NN )_) as_IN additional_JJ predictors_NNS ._. Table_NNP 5_CD provides_VBZ
        the_DT percentages_NNS of_IN each_DT ethnic_JJ group_NN receiving_VBG a_DT given_VBN
        treatment_NN by_IN stage_NN ._. With_IN the_DT inclusion_NN of_IN treatment_NN
        variables_NNS ,_, ethnic_JJ differences_NNS were_VBD no_DT longer_RB significant_JJ in_IN
        the_DT third_JJ cohort_NN ,_, but_CC remained_VBD significant_JJ in_IN the_DT first_JJ two_CD
        [_NN Likelihood_NNP Ratio_NNP χ_NN 2_CD (_( 4_LS )_) =_SYM 25_CD ._. 3_LS ,_, 29_CD ._. 1_LS ,_, and_CC 8_CD ._. 2_CD ;_: 
        p_NN <_NN ._. 0001_CD ,_, 
        p_NN <_NN ._. 0001_CD ,_, and_CC 
        p_NN =_SYM ._. 08_CD respectively_RB ]_NN ._. See_VB Figure_NN
        2_CD ._.
        Additionally_RB ,_, we_PRP tested_VBD the_DT post_NN hoc_FW hypothesis_NNS that_IN
        Hawaiians_NNP have_VBP lower_JJR survival_NN because_IN they_PRP were_VBD both_DT
        younger_JJR and_CC diagnosed_VBN at_IN a_DT more_JJR advanced_VBD stage_NN than_IN the_DT
        other_JJ groups_NNS ._. If_IN advanced_JJ disease_NN is_VBZ more_RBR aggressive_JJ in_IN
        young_JJ people_NNS ,_, this_DT could_MD explain_VB why_WRB the_DT Hawaiians_NNP had_VBD
        lower_JJR survival_NN ._. An_DT interaction_NN term_NN between_IN age_NN and_CC stage_NN
        at_IN diagnosis_NN was_VBD created_VBN and_CC added_VBN to_TO the_DT models_NNS run_VBP
        previously_RB ._. However_RB this_DT interaction_NN term_NN did_VBD not_RB show_VB
        statistical_JJ significance_NN ,_, failing_VBG to_TO support_VB the_DT post_NN hoc_FW
        hypothesis_NNS ._.
        At_IN least_JJS for_IN cohort_NN 3_CD ,_, our_PRP$ data_NNS also_RB allowed_VBN us_PRP to_TO
        compare_VB the_DT predictive_JJ value_NN of_IN the_DT SEER_NNP staging_NN variable_JJ
        (_( local_JJ ,_, region_NN ,_, and_CC distant_JJ )_) with_IN that_DT of_IN the_DT more_RBR
        comprehensive_JJ TNM_NNP staging_NN variable_JJ ._. TNM_NNP staging_NN provided_VBN
        significantly_RB improved_VBN predictive_JJ value_NN over_IN SEER_NNP staging_NN
        [_NN Likelihood_NNP Ratio_NNP χ_NN 2_CD (_( 1_LS )_) =_SYM 126_CD ._. 4_LS ;_: 
        p_NN <_NN ._. 0001_CD ]_NN ._. However_RB ,_, inclusion_NN of_IN
        TNM_NNP staging_NN did_VBD not_RB eliminate_VB the_DT Hawaiian_JJ ethnic_JJ disparity_NN
        in_IN outcome_NN [_NN Likelihood_NNP Ratio_NNP χ_NN 2_CD (_( 4_LS )_) =_SYM 11_CD ._. 7_CD ,_, 
        p_NN <_NN ._. 05_CD ]_NN ,_, again_RB suggesting_VBG that_DT
        stage_NN at_IN diagnosis_NN alone_RB does_VBZ not_RB account_VB for_IN the_DT
        persistently_RB low_JJ survival_NN among_IN Hawaiians_NNP ._.
      
      
        Discussion_NNP
        With_IN few_JJ exceptions_NNS ,_, results_NNS clearly_RB supported_VBD the_DT
        stated_VBN hypothesis_NNS that_IN ethnic_JJ disparities_NNS in_IN colorectal_NN
        cancer_NN survival_NN have_VBP been_VBN diminishing_VBG over_IN time_NN ._. Figure_NN 1_CD ,_,
        showing_VBG the_DT convergence_NN of_IN survival_NN over_IN time_NN ,_, best_JJS
        exemplifies_VBZ this_DT ._. The_DT one_CD discrepancy_NN in_IN this_DT overall_JJ trend_NN
        is_VBZ the_DT unchanged_JJ life_NN expectancy_NN for_IN the_DT Hawaiian_JJ group_NN in_IN
        cohort_NN 3_CD ._. A_DT comparison_NN with_IN the_DT survival_NN curves_NNS for_IN other_JJ
        causes_NNS of_IN death_NN within_IN cohort_NN 3_CD reveals_VBZ that_IN this_DT effect_NN is_VBZ
        specific_JJ to_TO colorectal_NN cancer_NN and_CC does_VBZ not_RB reflect_VB a_DT
        general_JJ tendency_NN for_IN Hawaiians_NNP to_TO die_VB sooner_RBR ._.
        One_CD possible_JJ explanation_NN for_IN this_DT is_VBZ that_IN Hawaiians_NNP were_VBD
        not_RB utilizing_VBG medical_JJ care_NN to_TO treat_VB colorectal_NN cancer_NN to_TO
        the_DT same_JJ degree_NN as_IN other_JJ ethnic_JJ groups_NNS ._. Our_PRP$ post_NN hoc_FW
        analyses_NNS did_VBD demonstrate_VB that_IN ethnic_JJ disparities_NNS were_VBD no_RB
        longer_RB statistically_RB significant_JJ after_IN controlling_VBG for_IN
        treatment_NN differences_NNS ._. Interestingly_RB ,_, however_RB ,_, Hawaiians_NNP
        did_VBD not_RB appear_VB to_TO be_VB receiving_VBG less_JJR treatment_NN ;_: and_CC with_IN
        respect_NN to_TO chemotherapy_NN and_CC radiation_NN ,_, appear_VB to_TO have_VB been_VBN
        receiving_VBG more_JJR than_IN the_DT other_JJ ethnic_JJ groups_NNS ._. One_CD possible_JJ
        explanation_NN for_IN this_DT is_VBZ that_DT treatment_NN is_VBZ causing_VBG adverse_JJ
        effects_NNS and_CC death_NN ._. Another_DT is_VBZ that_IN doctors_NNS see_VBP prognostic_JJ
        signs_NNS of_IN severe_JJ disease_NN that_WDT are_VBP not_RB measured_VBN by_IN our_PRP$
        covariates_NNS ,_, and_CC therefore_RB prescribe_VB more_JJR treatment_NN ._. That_DT
        is_VBZ ,_, Hawaiians_NNP may_MD have_VB more_JJR advanced_VBN disease_NN than_IN staging_NN
        alone_RB indicates_VBZ ._.
        The_DT implications_NNS of_IN these_DT findings_NNS are_VBP important_JJ ._. If_IN
        differential_NN screening_NN constitutes_VBZ the_DT primary_JJ reason_NN for_IN
        ethnic_JJ survival_NN disparities_NNS ,_, it_PRP should_MD be_VB possible_JJ to_TO
        achieve_VB equally_RB favorable_JJ outcomes_NNS in_IN all_DT ethnic_JJ groups_NNS ._.
        With_IN the_DT exception_NN of_IN the_DT Hawaiians_NNP ,_, the_DT evidence_NN presented_VBN
        here_RB reflects_VBZ a_DT convergence_NN in_IN terms_NNS of_IN screening_NN ,_, medical_JJ
        care_NN ,_, and_CC colorectal_NN cancer_NN survival_NN among_IN all_DT ethnic_JJ
        groups_NNS ._. Further_RB efforts_NNS are_VBP needed_VBN to_TO examine_VB why_WRB Hawaiians_NNP
        do_VBP not_RB follow_VB the_DT overall_JJ trend_NN ,_, and_CC how_WRB to_TO make_VB
        improvements_NNS ._. In_IN this_DT regard_NN ,_, a_DT Native_NNP Hawaiian_JJ cancer_NN
        network_NN called_VBD the_DT Imi_NNP Hale_NNP is_VBZ attempting_VBG ,_, along_IN with_IN
        support_NN from_IN the_DT National_NNP Cancer_NNP Institute_NNP ,_, to_TO increase_VB
        screening_NN for_IN colorectal_NN cancer_NN in_IN Native_NNP Hawaiians_NNP ._. [_NN 27_CD
        ]_NN
        One_CD limitation_NN of_IN this_DT study_NN is_VBZ that_IN data_NNS are_VBP restricted_VBN
        to_TO the_DT state_NN of_IN Hawaii_NNP ._. However_RB ,_, even_RB though_IN there_EX are_VBP
        clearly_RB potential_JJ regional_JJ differences_NNS in_IN ethnic_JJ patterns_NNS
        of_IN survival_NN ,_, the_DT results_NNS of_IN this_DT study_NN could_MD be_VB important_JJ
        beyond_IN Hawaii_NNP ._. For_IN example_NN ,_, in_IN national_JJ studies_NNS ,_, it_PRP has_VBZ
        been_VBN shown_VBN that_IN African-_NNP Americans_NNPS are_VBP less_RBR likely_JJ than_IN
        others_NNS to_TO receive_VB adjuvant_NN chemotherapy_NN ._. [_NN 28_CD ]_NN
        Differential_NNP treatment_NN utilization_NN may_MD drive_VB ethnic_JJ outcome_NN
        disparities_NNS ._. The_DT role_NN of_IN individual_JJ patient_NN choice_NN and_CC the_DT
        role_NN of_IN complicating_VBG co-morbid_JJ conditions_NNS in_IN treatment_NN
        selection_NN probably_RB play_VB some_DT role_NN ,_, and_CC another_DT limitation_NN
        of_IN our_PRP$ study_NN is_VBZ not_RB having_VBG access_NN to_TO this_DT information_NN ._. In_IN
        future_JJ studies_NNS ,_, however_RB ,_, we_PRP hope_VBP to_TO elucidate_NN the_DT impact_NN of_IN
        such_JJ factors_NNS ._.
        To_TO this_DT end_NN ,_, an_DT important_JJ area_NN for_IN future_JJ research_NN is_VBZ
        detailed_VBN analysis_NN of_IN specific_JJ treatments_NNS received_VBN by_IN cancer_NN
        patients_NNS ._. For_IN example_NN ,_, beginning_VBG in_IN 1988_CD (_( the_DT start_NN of_IN the_DT
        third_JJ cohort_NN in_IN the_DT present_JJ study_NN )_) colorectal_NN cancer_NN
        survival_NN has_VBZ been_VBN improved_VBN through_IN the_DT use_NN of_IN
        5_CD -_: fluorouracil-leucovorin_JJ as_IN adjuvant_NN chemotherapy_NN ._. [_NN 29_CD ]_NN
        This_DT factor_NN ,_, as_RB well_RB as_IN improving_VBG stage_NN distribution_NN
        through_IN screening_NN ,_, has_VBZ undoubtedly_RB contributed_VBN to_TO the_DT
        greatly_RB improved_VBN colorectal_NN cancer_NN survival_NN rates_NNS in_IN the_DT
        third_JJ cohort_NN ._. Unfortunately_RB ,_, the_DT HTR_NNP does_VBZ not_RB provide_VB
        adequate_JJ detail_NN with_IN respect_NN to_TO specific_JJ chemotherapy_NN
        treatments_NNS ,_, so_IN this_DT hypothesis_NNS could_MD not_RB be_VB examined_VBN here_RB ._.
        However_RB ,_, future_JJ studies_NNS incorporating_VBG expanded_VBN data_NNS sources_NNS
        should_MD examine_VB whether_IN Hawaiians_NNP have_VBP been_VBN receiving_VBG
        adjuvant_NN 5_CD -_: FU-leucovorin_NNP to_TO the_DT same_JJ degree_NN as_IN others_NNS ,_, and_CC
        if_IN not_RB ,_, why_WRB not_RB (_( e_SYM ._. g_SYM ._. ,_, access_NN ,_, informed_VBN choice_NN with_IN refusal_NN
        of_IN recommended_JJ treatment_NN ,_, or_CC co-morbid_JJ disease_NN )_) ._.
        Conversely_RB ,_, if_IN Hawaiians_NNP receive_VB apparently_RB similar_JJ
        adjuvant_NN therapy_NN (_( i_NNP ._. e_SYM ._. ,_, same_JJ agents_NNS ,_, dosage_NN ,_, number_NN of_IN
        courses_NNS ,_, etc_FW ._. )_) ,_, do_VBP they_PRP benefit_VBP to_TO the_DT same_JJ degree_NN as_IN
        others_NNS ?_. Also_RB ,_, do_VBP they_PRP show_VBP a_DT similar_JJ degree_NN of_IN treatment_NN
        compliance_NN ?_. These_DT issues_NNS may_MD be_VB of_IN particular_JJ relevance_NN ,_,
        because_IN results_NNS from_IN this_DT study_NN suggest_VBP that_IN Hawaiians_NNP are_VBP
        equally_RB likely_JJ ,_, if_IN not_RB more_RBR likely_JJ ,_, to_TO receive_VB
        treatments_NNS ._.
        Hawaiians_NNP have_VBP been_VBN reported_VBN to_TO have_VB relatively_RB high_JJ
        rates_NNS of_IN diabetes_NN ,_, renal_JJ and_CC vascular_NN disease_NN ,_, and_CC tend_VBP to_TO
        be_VB afflicted_VBN at_IN a_DT younger_JJR age_NN ._. Perhaps_RB an_DT interaction_NN
        between_IN cancer_NN treatment_NN and_CC comorbid_NN conditions_NNS is_VBZ having_VBG
        a_DT negative_JJ effect_NN on_IN Hawaiians_NNP ._. We_PRP speculate_VBP that_IN co-morbid_JJ
        illness_NN might_MD play_VB a_DT role_NN in_IN treatment_NN selection_NN for_IN some_DT
        individuals_NNS with_IN colorectal_NN cancer_NN ._. Collection_NNP of_IN ICD-_NNP 9_CD
        diagnosis_NN codes_NNS from_IN non-_NN HRT_NNP sources_NNS with_IN appropriate_JJ
        record_NN linkage_NN would_MD allow_VB us_PRP to_TO study_VB this_DT ._.
        Other_JJ results_NNS from_IN this_DT study_NN indicate_VBP that_DT age_NN at_IN
        diagnosis_NN is_VBZ another_DT significant_JJ predictor_NN of_IN survival_NN ,_,
        with_IN older_JJR individuals_NNS having_VBG a_DT shorter_JJR life_NN expectancy_NN
        after_IN diagnosis_NN ._. However_RB ,_, a_DT comparison_NN of_IN hazard_NN ratios_NNS by_IN
        cause_NN of_IN death_NN showed_VBD that_IN the_DT values_NNS were_VBD much_RB lower_JJR for_IN
        death_NN due_JJ to_TO colorectal_NN cancer_NN than_IN for_IN other_JJ causes_NNS ._. This_DT
        suggests_VBZ that_IN ,_, while_IN age_NN is_VBZ clearly_RB related_VBN to_TO overall_JJ
        survival_NN ,_, it_PRP is_VBZ less_RBR relevant_JJ to_TO colorectal_NN cancer_NN
        survival_NN ._. That_DT is_VBZ ,_, colon_NN cancer_NN is_VBZ not_RB more_RBR deadly_JJ for_IN
        older_JJR individuals_NNS than_IN for_IN younger_JJR ones_NNS ._. Similarly_RB ,_, sex_NN
        appears_VBZ to_TO predict_VB colorectal_NN cancer_NN survival_NN ._. A_DT small_JJ
        beneficial_JJ effect_NN was_VBD observed_VBN for_IN women_NNS when_WRB considering_VBG
        death_NN due_JJ to_TO colorectal_NN cancer_NN ,_, but_CC a_DT strong_JJ effect_NN when_WRB
        considering_VBG death_NN due_JJ to_TO other_JJ causes_NNS ._. The_DT impact_NN of_IN
        co-morbid_JJ disease_NN on_IN survival_NN might_MD explain_VB these_DT age_NN and_CC
        gender_NN differentials_NNS ._.
        Stage_NN at_IN diagnosis_NN represents_VBZ the_DT most_RBS important_JJ
        prognostic_JJ variable_NN ._. In_IN this_DT study_NN the_DT SEER_NNP staging_NN system_NN
        was_VBD used_VBN so_IN that_IN identical_JJ analyses_NNS could_MD be_VB performed_VBN
        across_IN all_DT three_CD cohorts_NNS ._. However_RB ,_, for_IN the_DT most_RBS recent_JJ
        cohort_NN (_( cohort_NN 3_LS )_) ,_, TNM_NNP staging_NN clearly_RB improved_VBD survival_NN
        predictions_NNS over_IN the_DT less_RBR comprehensive_JJ SEER_NNP staging_NN ._. In_IN
        future_JJ studies_NNS ,_, we_PRP will_MD use_VB TNM_NNP staging_NN whenever_WRB
        possible_JJ ._.
      
      
        Conclusions_NNP
        This_DT study_NN provided_VBD longitudinal_NN evidence_NN in_IN support_NN of_IN
        non-biologic_JJ explanations_NNS for_IN ethnic_JJ disparities_NNS in_IN
        colorectal_NN cancer_NN survival_NN ._. Specifically_RB ,_, the_DT present_JJ
        analysis_NN suggests_VBZ that_WDT observed_VBN ethnic_JJ differences_NNS result_VBP
        from_IN differential_NN screening_NN ._. In_IN Hawaii_NNP ,_, ethnic_JJ disparities_NNS
        in_IN colorectal_NN cancer_NN survival_NN have_VBP narrowed_VBN considerably_RB
        over_IN the_DT past_JJ 30_CD years_NNS ._. However_RB ,_, Hawaiian_JJ patients_NNS did_VBD not_RB
        experience_VB the_DT same_JJ degree_NN of_IN improvement_NN in_IN survival_NN as_IN
        the_DT other_JJ ethnic_JJ groups_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        IP_NNP participated_VBD in_IN the_DT design_NN of_IN the_DT study_NN ,_, drafted_VBD the_DT
        manuscript_NN ,_, and_CC performed_VBD the_DT statistical_JJ analyses_NNS ._. SM_NNP ,_, SD_NNP ,_,
        SH_NNP ,_, and_CC GM_NNP participated_VBD in_IN the_DT design_NN of_IN the_DT study_NN ._.
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
